185 related articles for article (PubMed ID: 8750369)
1. Variability in the pharmacokinetics and pharmacodynamics of low dose aspirin in healthy male volunteers.
Benedek IH; Joshi AS; Pieniaszek HJ; King SY; Kornhauser DM
J Clin Pharmacol; 1995 Dec; 35(12):1181-6. PubMed ID: 8750369
[TBL] [Abstract][Full Text] [Related]
2. A randomized trial to assess the pharmacodynamics and pharmacokinetics of a single dose of an extended-release aspirin formulation.
Patrick J; Dillaha L; Armas D; Sessa WC
Postgrad Med; 2015 Aug; 127(6):573-80. PubMed ID: 25998572
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and pharmacodynamics of the antiplatelet combination aspirin (acetylsalicylic acid) plus extended-release dipyridamole are not altered by coadministration with the potent CYP2C19 inhibitor omeprazole.
Offman E; Schobelock MJ; Brickl R; VanderMaelen CP; Ehrlich J; Eisert W
Am J Cardiovasc Drugs; 2013 Apr; 13(2):113-20. PubMed ID: 23532686
[TBL] [Abstract][Full Text] [Related]
4. Pharmacodynamics and pharmacokinetics of a novel, low-dose, soft-gel capsule of acetylsalicylic acid in comparison with an oral solution after single-dose administration to healthy volunteers: a phase I, two-way crossover study.
Loprete L; Leuratti C; Scarsi C; Radicioni M
Clin Drug Investig; 2014 Jan; 34(1):19-25. PubMed ID: 24132773
[TBL] [Abstract][Full Text] [Related]
5. Investigation into the causes of aspirin resistance in healthy dogs.
Haines JM; Lee PM; Hegedus RM; Hwang JK; Court MH
J Vet Pharmacol Ther; 2019 Mar; 42(2):160-170. PubMed ID: 30302763
[TBL] [Abstract][Full Text] [Related]
6. Actions and interactions of acetylsalicylic acid, salicylic acid and diflunisal on platelet aggregation.
Nitelius E; Brantmark B; Fredholm B; Hedner U; Forshell GP; Wåhlin-Boll E; Melander A
Eur J Clin Pharmacol; 1984; 27(2):165-8. PubMed ID: 6499897
[TBL] [Abstract][Full Text] [Related]
7. Biphasic initial phase of platelet aggregation inhibition after oral aspirin.
Walter E; Zimmermann R; Siess R; Staiger C; Weber E
Artery; 1980; 8(5):501-6. PubMed ID: 7213053
[TBL] [Abstract][Full Text] [Related]
8. Differences in the influence of the interaction between acetylsalicylic acid and salicylic acid on platelet function in whole blood and isolated platelets: influence of neutrophils.
González-Correa JA; Muñoz-Marín J; López-Villodres JA; Navas MD; Guerrero A; Torres JA; De La Cruz JP
Pharmacol Res; 2007 Aug; 56(2):168-74. PubMed ID: 17644353
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic and pharmacodynamic profiles of a novel phospholipid-aspirin complex liquid formulation and low dose enteric-coated aspirin: results from a prospective, randomized, crossover study.
Franchi F; Schneider DJ; Prats J; Fan W; Rollini F; Been L; Taatjes-Sommer HS; Bhatt DL; Deliargyris EN; Angiolillo DJ
J Thromb Thrombolysis; 2022 Oct; 54(3):373-381. PubMed ID: 36036856
[TBL] [Abstract][Full Text] [Related]
10. Plasma levels of aspirin following effervescent and enteric coated tablets, and their effect on platelet function.
Ross-Lee LM; Elms MJ; Cham BE; Bochner F; Bunce IH; Eadie MJ
Eur J Clin Pharmacol; 1982; 23(6):545-51. PubMed ID: 7160424
[TBL] [Abstract][Full Text] [Related]
11. Absorption kinetics of low-dose chewable aspirin--implications for acute coronary syndromes.
Hobl EL; Schmid RW; Stimpfl T; Ebner J; Jilma B
Eur J Clin Invest; 2015 Jan; 45(1):13-7. PubMed ID: 25402445
[TBL] [Abstract][Full Text] [Related]
12. Effect of transdermic acetylsalicylic acid on hemostasis in healthy volunteers.
Martínez AB; Funosas E; Maestri L; Lucena PH
Acta Odontol Latinoam; 2007; 20(1):3-8. PubMed ID: 18046964
[TBL] [Abstract][Full Text] [Related]
13. Orally given gastroprotective capsaicin does not modify aspirin-induced platelet aggregation in healthy male volunteers (human phase I examination).
Sandor B; Papp J; Mozsik G; Szolcsanyi J; Keszthelyi Z; Juricskay I; Toth K; Habon T
Acta Physiol Hung; 2014 Dec; 101(4):429-37. PubMed ID: 25532954
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of low-dose oral modified release, soluble and intravenous aspirin in man, and effects on platelet function.
Bochner F; Williams DB; Morris PM; Siebert DM; Lloyd JV
Eur J Clin Pharmacol; 1988; 35(3):287-94. PubMed ID: 3181281
[TBL] [Abstract][Full Text] [Related]
15. Assessment of efficacy of single dose acetylsalicylic acid over a 24-hour period.
Baha RM; Özdöl Ç; Güleç S; Erol Ç
Turk Kardiyol Dern Ars; 2015 Jul; 43(5):443-9. PubMed ID: 26148076
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the pharmacodynamics of acetylsalicylic acid 81 mg with or without esomeprazole 20 mg in healthy volunteers.
Andersson T; Morrison D; Nagy P; Pisupati J; Schettler J; Warner TD
Am J Cardiovasc Drugs; 2012 Aug; 12(4):217-24. PubMed ID: 22631032
[TBL] [Abstract][Full Text] [Related]
17. Utility of VerifyNow to assess the immediate pharmacodynamic response of chewed and swallowed aspirin: comparison with aggregometry.
Bliden KP; Kundan P; Kraft D; Parekh R; Singh S; Babu AD; Shah AP; Tantry US; Gurbel PA
Platelets; 2024 Dec; 35(1):2298352. PubMed ID: 38166614
[TBL] [Abstract][Full Text] [Related]
18. Plasma concentrations and anti-platelet effects after low dose acetylsalicylic acid.
Rosenkranz B; Frölich JC
Prostaglandins Leukot Med; 1985 Sep; 19(3):289-300. PubMed ID: 3864170
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of platelet function by a controlled release acetylsalicylic acid formulation--single and chronic dosing studies.
Roberts MS; McLeod LJ; Cossum PA; Vial JH
Eur J Clin Pharmacol; 1984; 27(1):67-74. PubMed ID: 6436031
[TBL] [Abstract][Full Text] [Related]
20. Acetylsalicylic acid in critically ill patients: a cross-sectional and a randomized trial.
Schoergenhofer C; Hobl EL; Schwameis M; Gelbenegger G; Staudinger T; Heinz G; Speidl WS; Zauner C; Reiter B; Lang I; Jilma B
Eur J Clin Invest; 2017 Jul; 47(7):504-512. PubMed ID: 28556061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
